Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis

200896 citationsJournal Article

Authors

Once-monthly oral Ibandronate for 12 months improved hip and spine BMD measured by QCT and DXA and strength estimated by FEA of QCT scans.

Good health and well-being

Published in: The Journal of Clinical Endocrinology & Metabolism

Volume 94, Issue 1, pp. 171-180

Field-Weighted Citation Impact: 4.74